Patents by Inventor Martina Von Freyburg
Martina Von Freyburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8940309Abstract: The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.Type: GrantFiled: September 4, 2014Date of Patent: January 27, 2015Assignee: Boehringer Ingelheim Vetmedica, Inc.Inventors: William Charles Ohnesorge, Isabelle Freiin Von Richthofen, Marika Christine Genzow, Martina Von Freyburg, Carola Kissel, Luc-Etienne Fabry, Knut Elbers, Kathleen Kwan Young Park
-
Publication number: 20140370058Abstract: The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.Type: ApplicationFiled: September 4, 2014Publication date: December 18, 2014Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBHInventors: William Charles OHNESORGE, Isabelle FREIIN VON RICHTHOFEN, Marika Christine GENZOW, Martina VON FREYBURG, Carola KISSEL, Luc-Etienne FABRY, Knut ELBERS, Kathleen Kwan Young PARK
-
Patent number: 8852613Abstract: The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.Type: GrantFiled: April 24, 2013Date of Patent: October 7, 2014Assignee: Boehringer Ingelheim Vetmedica, Inc.Inventors: William Charles Ohnesorge, Isabelle Freiin von Richthofen, Marika Christine Genzow, Martina von Freyburg, Carola Kissel, Luc-Etienne Fabry, Knut Elbers, Kathleen Kwan Young Park
-
Patent number: 8778355Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.Type: GrantFiled: February 1, 2012Date of Patent: July 15, 2014Assignee: Boehringer Ingelheim Vetmedica GmbHInventors: Knut Elbers, Christiane Fetzer, Martina von Freyburg, Gregor Meyers
-
Publication number: 20130230558Abstract: The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.Type: ApplicationFiled: April 24, 2013Publication date: September 5, 2013Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBHInventors: Wiliam Charles OHNESORGE, Isabelle FREIIN VON RICHTHOFEN, Marika Christine GENZOW, Martina VON FREYBURG, Carola KISSEL, Luc-Etienne FABRY, Knut ELBERS, Kathleen Kwan Young PARK
-
Patent number: 8444989Abstract: The present invention provides a one phase, aqueous vaccine composition for immunizing an animal against infection by Mycoplasma hyopneumoniae, comprising: an immunizing amount of a Mycoplasma hyopneumoniae bacterin, an acrylic acid polymer in the concentration range between 0.8 and 1.2 mg/ml, and a pharmaceutically acceptable carrier, and substantially no oil. It is especially useful for immunizing a pig against infection by Mycoplasma hyopneumoniae for at least 20 weeks after a single administration, which effective immunity is reached within 4 weeks after vaccination.Type: GrantFiled: April 14, 2009Date of Patent: May 21, 2013Assignee: Boehringer Ingelheim Vetmedica GmbHInventors: Wiliam Charles Ohnesorge, Isabelle Freiin von Richthofen, Marika Genzow, Martina von Freyburg, Carola Kissel, Luc-Etienne Fabry, Knut Elbers, Kathleen Park
-
Publication number: 20120201850Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.Type: ApplicationFiled: February 1, 2012Publication date: August 9, 2012Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBHInventors: Knut Elbers, Christiane Meyer, Martina von Freyburg, Gregor Meyers
-
Publication number: 20090226488Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Ems and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Ems in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.Type: ApplicationFiled: May 11, 2009Publication date: September 10, 2009Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBHInventors: Gregor MEYERS, Andreas EGE, Christiane MEYER, Martina von FREYBURG
-
Patent number: 7572455Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.Type: GrantFiled: May 19, 2005Date of Patent: August 11, 2009Assignee: Boehringer Ingelheim Vetmedica GmbHInventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg
-
Publication number: 20070015203Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.Type: ApplicationFiled: September 20, 2006Publication date: January 18, 2007Inventors: Knut Elbers, Christiane Meyer, Martina Von Freyburg, Gregor Meyers
-
Patent number: 7135561Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.Type: GrantFiled: September 6, 2002Date of Patent: November 14, 2006Assignee: Boehringer Ingelheim Vetmedica GmbHInventors: Knut Elbers, Christiane Meyer, Martina Von Freyburg, Gregor Meyers
-
Publication number: 20050287171Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.Type: ApplicationFiled: May 19, 2005Publication date: December 29, 2005Applicant: Boehringer Ingelheim Vetmedica GmbHInventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg
-
Publication number: 20040038198Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.Type: ApplicationFiled: September 6, 2002Publication date: February 26, 2004Applicant: Boehringer Ingelheim Vetmedica GmbHInventors: Knut Elbers, Christiane Meyer, Martina Von Freyburg, Gregor Meyers